Antonio Rosi Selected Research

Radioimmunotherapy

4/2006	Low and high tenascin-expressing tumors are efficiently targeted by ST2146 monoclonal antibody.
10/2005	Improved tumor targeting by combined use of two antitenascin antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Rosi Research Topics

Disease

11	Neoplasms (Cancer) 03/2019 - 10/2005
2	Carcinoma (Carcinomatosis) 01/2019 - 04/2006
1	COVID-19 01/2022
1	Infections 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Tongue Neoplasms (Tongue Neoplasm) 09/2015
1	Paralysis (Palsy) 10/2014
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Lung Neoplasms (Lung Cancer) 10/2014
1	Breast Neoplasms (Breast Cancer) 09/2011
1	Glioblastoma (Glioblastoma Multiforme) 04/2006

Drug/Important Bio-Agent (IBA)

5	Radioisotopes (Radionuclides)IBA 01/2019 - 01/2009
4	Biotin (Vitamin H)FDA Link 03/2019 - 01/2009
3	Cetuximab (Erbitux)FDA Link 03/2019 - 10/2014
3	TenascinIBA 01/2019 - 10/2005
3	Monoclonal AntibodiesIBA 01/2019 - 04/2006
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 04/2017
2	AntibodiesIBA 04/2017 - 10/2005
1	Immunoglobulin FragmentsIBA 01/2022
1	Vascular Endothelial Growth Factor CIBA 03/2019
1	Cisplatin (Platino)FDA LinkGeneric 03/2019
1	Histones (Histone)IBA 01/2019
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	TubulinIBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	EnzymesIBA 01/2019
1	pertuzumabIBA 04/2017
1	ErbB Receptors (EGF Receptor)IBA 04/2017
1	Panitumumab (Vectibix)FDA Link 04/2017
1	AerosolsIBA 10/2014
1	AvidinIBA 10/2010
1	AntidotesIBA 10/2010
1	OxavidinIBA 01/2009
1	Artificial ReceptorsIBA 01/2009
1	ST2146biotIBA 04/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2005

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2005
2	Radioimmunotherapy 04/2006 - 10/2005
1	Intranasal Administration 01/2022
1	Precision Medicine 01/2019